A COMPOSITION WITH A FUNGAL (YEAST) LIPASE AND METHOD FOR TREATING LIPID MALABSORPTION IN CYSTIC FIBROUS AS WELL AS PEOPLE SUFFERING FROM PANCREATIC LIPASE INSUFFICIENCY

The invention provides compositions and methods for treating pancreatic enzyme insufficiency, such as the pancreatic enzyme insufficiency associated with cystic fibrosis. The invention also provides compositions comprising lipase from Candida cylindracea, alone or in combination with amylase or amyl...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	SCHULER, EDWARD, F, SCHULER, CHRISTOPHER
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	AGRICULTURE ANIMAL HUSBANDRY BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES FISHING FORESTRY HUMAN NECESSITIES HUNTING INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING PEST REPELLANTS OR ATTRACTANTS PHYSICS PLANT GROWTH REGULATORS PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTSTHEREOF TESTING TRAPPING
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention provides compositions and methods for treating pancreatic enzyme insufficiency, such as the pancreatic enzyme insufficiency associated with cystic fibrosis. The invention also provides compositions comprising lipase from Candida cylindracea, alone or in combination with amylase or amyloglucosidase, protease and/or lactase. Furthermore, the invention discloses methods for treating pancreatic enzyme insufficiency comprising administering compositions to patients in need thereof. La présente invention se rapporte à des compositions et à des méthodes permettant de traiter l'insuffisance pancréatique, telle que l'insuffisance pancréatique associée à la mucoviscidose. L'invention a également trait à des compositions contenant une lipase extraite de Candida cylindracea, seule ou en combinaison avec une amylase ou une amyloglucosidase, une protéase et/ou une lactase. En outre, l'invention concerne des méthodes de traitement de l'insuffisance pancréatique, qui consistent à administrer lesdites compositions à des patients concernés.